Neuroblastoma UK

Also known as: The Neuroblastoma Society

Neuroblastoma UK raises money to fund scientific research into the causes of neuroblastoma (a cancer affecting mainly young children) and improved treatments. It also provides support and advice to parents and others affected by the disease.

Email Charity

Activities & Mission

Areas of Operation

Where this charity is registered to operate, as self-declared to the Charity Commission. These are regulatory classifications, not a list of active programmes, and don't necessarily indicate fundraising activity in each location.

Country

Northern Ireland Scotland

Region

England And Wales

Financial Information

Latest Income

£303,350

Latest Expenditure

£1,185,345

Financial Efficiency

Program Ratio 21.7%

% of income going directly to charitable activities

Higher than 9% of UK Beneficiary group charities with income £100K to £1M (sample: 3459). How is this calculated?

Overall Efficiency 95.6%

% of expenditure going to programs (vs overhead)

Higher than 36% of UK Beneficiary group charities with income £100K to £1M. How is this calculated?

Administrative Ratio 100.0%

Overhead (fundraising + governance) as % of total expenditure

Lower overhead than 0% of UK Beneficiary group charities with income £100K to £1M. (Lower overhead is generally read as more efficient.) How is this calculated?

Latest Financial Breakdown

Income Sources

Donations & Legacies £366,478

Charitable Activities £51,607

Other Trading £0

Investments £32,349

Other Income £214,525

Expenditure Categories

Charitable Expenditure £144,403

Raising Funds £6,699

Governance £144,403

Grants to Institutions £0

Other Expenditure £0

Financial Trend

Annual Returns

As filed with the Charity Commission for England and Wales. Most recent filing covers the financial year ending 2024.

One or more years show a significant change in income (over ±100%) compared with the prior year. This usually reflects a merger, transfer of activities, restated accounts, or a one-off legacy — not necessarily a real change in operating scale. See the methodology for context.

The Commission record shows this related event on the register:

Asset transfer in in 2019 — Smile with Siddy (organisation 5035988)

Financial Year	Income	Expenditure	Charitable Spending	Net Assets	Reserves	Staff
2024	£303,350	£1,185,345				0 / 4
2023	£664,959	£151,102	£144,403	£586,048	£586,048	3 / 5
2022	£268,417	£818,780				0 / 0
2021	£417,323	£121,683				0 / 0
2020	£340,908	£440,816				0 / 5

Staff column shows: Employees / Volunteers

Frequently asked questions about Neuroblastoma UK

What does Neuroblastoma UK do?

How much income did Neuroblastoma UK report in 2024?

Neuroblastoma UK reported total income of £303k and reported expenditure of £1.19m for the financial year ending 2024, based on the most recent annual return filed with the Charity Commission.

How efficient is Neuroblastoma UK?

Neuroblastoma UK has a program ratio of 21.7%, meaning that share of its income goes directly to charitable activities. This is higher than 9% of UK Beneficiary group charities with income £100K to £1M (sample of 3459 charities). See our methodology for how this is calculated.

When was Neuroblastoma UK registered as a charity?

Neuroblastoma UK was registered with the Charity Commission for England and Wales on 20 July 1983 as charity number 326385. It has been registered for 43 years.

Who runs Neuroblastoma UK?

Neuroblastoma UK is governed by a board of 10 trustees. Trustees are legally responsible for the charity's governance and are listed in full on its profile.

Where does Neuroblastoma UK operate?

Neuroblastoma UK operates across 3 areas: Northern Ireland, Scotland and England And Wales.

Is Neuroblastoma UK a registered charity?

Yes — Neuroblastoma UK is a registered charity in England and Wales, charity number 326385.